Gross Profit (Annual)

Gross Profit: Revenues from operations less the associated costs.

GSK PLC Sponsored ADR (GSK) had Gross Profit of $27.07B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$37.73B
Net Income	$6.13B
Cost of Goods Sold	$10.65B
Gross Profit	$27.07B
Operating Expenses	$29.33B
Operating Income	$8.39B
Non-Operating Income/Expense	$-847.10M
Pre-Tax Income	$7.54B
Normalized Pre-Tax Income	$7.55B
Income after Taxes	$6.60B
Income from Continuous Operations	$6.60B
Consolidated Net Income/Loss	$6.60B
Normalized Income after Taxes	$6.61B
EBIT	$8.39B
EBITDA	$11.24B
Weighted-Average Shares Outstanding (Basic)	2.03B
Weighted-Average Shares Outstanding (Diluted)	2.06B
Earnings per Share (EPS) (Basic)	$3.03
Earnings per Share (EPS) (Diluted)	$2.98
Balance Sheet Financials
Current Assets	$23.19B
Property, Plant, and Equipment	$11.22B
Long-Term Assets	$50.21B
Total Assets	$73.40B
Current Liabilities	$26.21B
Long-Term Debt	$18.91B
Long-Term Liabilities	$31.27B
Total Liabilities	$57.48B
Common Equity	$15.92B
Tangible Shareholders Equity	$-10.93B
Shareholders Equity	$15.92B
Common Shares Outstanding	2.16B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$8.42B
Cash Flow from Investing Activities	$-1.98B
Cash Flow from Financial Activities	$-7.02B
Beginning Cash	$4.26B
End Cash	$3.56B
Increase/Decrease in Cash	$-705.29M
Stock-Based Compensation	$381.88M
Common Stock Dividends Paid	$-2.80B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.88
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.54
Debt to Equity Ratio	1.41
Gross Margin	71.76%
Operating Margin	22.24%
EBIT Margin	22.24%
EBITDA Margin	29.80%
Pre-Tax Profit Margin	19.99%
Profit Margin	16.25%
Free Cash Flow	$6.82B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.51
Inventory Turnover	1.56
Receiveable Turnover	3.91
Days Sales in Receivables	93.37
Return on Equity	41.48%
Return on Tangible Equity	-60.43%
Return on Assets	9.00%
Return on Investments	18.96%
Book Value Per Share	$7.38
Free Cash Flow per Share	$3.32
Operating Cash Flow per Share	$4.10

Data from Zacks Investment Research, Inc.